NPI: 1619310513 · ARVIN, CA 93203 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/10/2013
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER, TREASURER) |
| NPI Enumeration Date | 04/10/2013 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,617 | $1.02M |
| 2019 | 7,128 | $776K |
| 2020 | 11,933 | $1.06M |
| 2021 | 13,802 | $1.11M |
| 2022 | 14,988 | $1.27M |
| 2023 | 11,223 | $1.52M |
| 2024 | 9,551 | $1.36M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 35,160 | 2,751 | $8.09M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 20,963 | 1,440 | $14K |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,269 | 901 | $5K |
| 90674 | 83 | 80 | $3K | |
| J1756 | Injection, iron sucrose, 1 mg | 7,014 | 1,565 | $3K |
| A4657 | Syringe, with or without needle, each | 1,894 | 716 | $2K |
| 90747 | 13 | 13 | $1K | |
| 90662 | 15 | 15 | $742.02 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 41 | 41 | $600.12 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,242 | 644 | $278.34 |
| 85048 | 386 | 367 | $67.09 | |
| 83970 | 422 | 367 | $67.09 | |
| 85041 | 401 | 382 | $67.09 | |
| 83540 | 105 | 102 | $0.00 | |
| 82108 | 14 | 14 | $0.00 | |
| 82607 | 13 | 13 | $0.00 | |
| 82728 | 134 | 130 | $0.00 | |
| 83550 | 73 | 71 | $0.00 |